Traws Pharma Inc (TRAW)
8.07
-0.96
(-10.63%)
USD |
NASDAQ |
Jan 08, 16:00
8.07
0.00 (0.00%)
Pre-Market: 08:56
Traws Pharma SG&A Expense (Quarterly): 3.48M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp | 0.946M |
| Design Therapeutics Inc | 4.37M |
| Emergent BioSolutions Inc | 76.60M |
| Marinus Pharmaceuticals Inc | 12.57M |
| NovaBay Pharmaceuticals Inc | 2.65M |